Frequently Asked Questions
Technological innovations enhancing biopsy needle efficacy & aging population contributing to higher biopsy rates are the growth drivers of the Latin America breast biopsy needle market.
Needle type, ergonomics, procedure, usability, application, end user and distribution channel are the factors on which the Latin America breast biopsy needle market research is based.
Major companies in the Latin America breast biopsy needle market are Medax SRL (Italy), Cook (U.S.), BD (U.S.), AprioMed AB (Sweden), INRAD Inc. (U.S.), Hologic, Inc. (U.S.), Möller Medical GmbH (Germany), IZI Medical Products (U.S.), Merit Medical Systems, Inc. (U.S.), ADRIA MEDICAL (France), Devicor Medical Products Inc. (U.S.), Remington Medical Inc. (U.S.), PAJUNK GmbH (Germany).
The Latin America breast biopsy needle market size will be worth USD 40.28 million by 2031.
The growth rate of the Latin America breast biopsy needle market is 7.7% in the forecast by 2031.
